The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals

N Engl J Med. 2015 Sep 17;373(12):1087-9. doi: 10.1056/NEJMp1507924. Epub 2015 Aug 19.

Authors

Jeremy A Greene¹, Elizabeth S Watkins

Affiliation

¹ From the Division of General Internal Medicine and the Department of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore (J.A.G.); and the Department of Anthropology, History and Social Medicine, University of California, San Francisco, School of Medicine, San Francisco (E.S.W.).

PMID: 26287749
DOI: 10.1056/NEJMp1507924

No abstract available

Publication types

Historical Article

MeSH terms

Advertising / legislation & jurisprudence*
Contraceptives, Oral / adverse effects
Contraceptives, Oral / history
Drug Industry / history
Drug Industry / legislation & jurisprudence
Drug Labeling / history*
Drug Labeling / legislation & jurisprudence
Drug-Related Side Effects and Adverse Reactions
Female
Government Regulation / history*
History, 20th Century
Humans
Legislation, Drug / history*
Prescription Drugs / adverse effects
Prescription Drugs / history*
Public Opinion
United States
United States Food and Drug Administration / history*

Substances

Contraceptives, Oral
Prescription Drugs